32 results on '"Tang, Yong"'
Search Results
2. The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review
- Author
-
Li, Ke-Ru, Wu, An-Guo, Tang, Yong, He, Xiao-Peng, Yu, Chong-Lin, Wu, Jian-Ming, Hu, Guang-Qiang, and Yu, Lu
- Published
- 2022
- Full Text
- View/download PDF
3. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice
- Author
-
Zhang, Shan-shan, Zhu, Lin, Peng, Yan, Zhang, Lei, Chao, Feng-lei, Jiang, Lin, Xiao, Qian, Liang, Xin, Tang, Jing, Yang, Hao, He, Qi, Guo, Yi-jing, Zhou, Chun-ni, and Tang, Yong
- Published
- 2022
- Full Text
- View/download PDF
4. Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
- Author
-
Zhou, Xiao-Gang, Qiu, Wen-Qiao, Yu, Lu, Pan, Rong, Teng, Jin-Feng, Sang, Zhi-Pei, Law, Betty Yuen-Kwan, Zhao, Ya, Zhang, Li, Yan, Lu, Tang, Yong, Sun, Xiao-Lei, Wong, Vincent Kam Wai, Yu, Chong-Lin, Wu, Jian-Ming, Qin, Da-Lian, and Wu, An-Guo
- Published
- 2022
- Full Text
- View/download PDF
5. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer’s Disease
- Author
-
Campos, Henrique C., Ribeiro, Deidiane Elisa, Hashiguchi, Debora, Hukuda, Deborah Y., Gimenes, Christiane, Romariz, Simone A. A., Ye, Qing, Tang, Yong, Ulrich, Henning, and Longo, Beatriz Monteiro
- Published
- 2022
- Full Text
- View/download PDF
6. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease‐related pathology via autophagy induction.
- Author
-
Long, Tao, Chen, Xue, Qin, Da‐Lian, Zhu, Yun‐Fei, Zhou, Yu‐Jia, He, Yan‐Ni, Fu, Hai‐Jun, Tang, Yong, Yu, Lu, Huang, Fei‐Hong, Wang, Long, Yu, Chong‐Lin, Law, Betty Yuen‐Kwan, Wu, Jian‐Ming, Wu, An‐Guo, and Zhou, Xiao‐Gang
- Abstract
Background: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder without an effective cure. Natural products, while showing promise as potential therapeutics for AD, remain underexplored. Aims: This study was conducted with the goal of identifying potential anti‐AD candidates from natural sources using Caenorhabditis elegans (C. elegans) AD‐like models and exploring their mechanisms of action. Materials & Methods: Our laboratory's in‐house herbal extract library was utilized to screen for potential anti‐AD candidates using the C. elegans AD‐like model CL4176. The neuroprotective effects of the candidates were evaluated in multiple C. elegans AD‐like models, specifically targeting Aβ‐ and Tau‐induced pathology. In vitro validation was conducted using PC‐12 cells. To investigate the role of autophagy in mediating the anti‐AD effects of the candidates, RNAi bacteria and autophagy inhibitors were employed. Results: The ethanol extract of air‐dried fruits of Luffa cylindrica (LCE), a medicine‐food homology species, was found to inhibit Aβ‐ and Tau‐induced pathology (paralysis, ROS production, neurotoxicity, and Aβ and pTau deposition) in C. elegans AD‐like models. LCE was non‐toxic and enhanced C. elegans' health. It was shown that LCE activates autophagy and its anti‐AD efficacy is weakened with the RNAi knockdown of autophagy‐related genes. Additionally, LCE induced mTOR‐mediated autophagy, reduced the expression of AD‐associated proteins, and decreased cell death in PC‐12 cells, which was reversed by autophagy inhibitors (bafilomycin A1 and 3‐methyladenine). Discussion: LCE, identified from our natural product library, emerged as a valuable autophagy enhancer that effectively protects against neurodegeneration in multiple AD‐like models. RNAi knockdown of autophagy‐related genes and cotreatment with autophagy inhibitors weakened its anti‐AD efficacy, implying a critical role of autophagy in mediating the neuroprotective effects of LCE. Conclusion: Our findings highlight the potential of LCE as a functional food or drug for targeting AD pathology and promoting human health. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. The effects of voluntary running exercise on the astrocytes of the medial prefrontal cortex in APP/PS1 mice.
- Author
-
Liu, Mei, Zhu, Lin, Guo, Yi‐jing, Zhang, Shan‐shan, Jiang, Lin, Zhang, Yi, Chao, Feng‐lei, and Tang, Yong
- Abstract
Pathological changes in the medial prefrontal cortex (mPFC) and astrocytes are closely associated with Alzheimer's disease (AD). Voluntary running has been found to effectively delay AD. However, the effects of voluntary running on mPFC astrocytes in AD are unclear. A total of 40 10‐month‐old male amyloid precursor protein/presenilin 1 (APP/PS1) mice and 40 wild‐type (WT) mice were randomly divided into control and running groups, and the running groups underwent voluntary running for 3 months. Mouse cognition was assessed by the novel object recognition (NOR), Morris water maze (MWM), and Y maze tests. The effects of voluntary running on mPFC astrocytes were investigated using immunohistochemistry, immunofluorescence, western blotting, and stereology. APP/PS1 mice performed significantly worse than WT mice in the NOR, MWM, and Y maze tests, and voluntary running improved the performance of APP/PS1 mice in these tests. The total number of mPFC astrocytes was increased, cell bodies were enlarged, and protrusion number and length were increased in AD mice compared with WT mice, but there was no difference in component 3 (C3) levels in the mPFC (total mPFC level); however, C3 and S100B levels in astrocytes were increased in AD mice. Voluntary running reduced the total number of astrocytes and S100B levels in astrocytes and increased the density of PSD95+ puncta in direct contact with astrocyte protrusions in the APP/PS1 mouse mPFC. Three months of voluntary running inhibited astrocyte hyperplasia and S100B expression in astrocytes, increased the density of synapses in contact with astrocytes, and improved cognitive function in APP/PS1 mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Berberine Rescues D-Ribose-Induced Alzheimer's Pathology via Promoting Mitophagy.
- Author
-
Wang, Chuanling, Zou, Qian, Pu, Yinshuang, Cai, Zhiyou, and Tang, Yong
- Subjects
BERBERINE ,ALZHEIMER'S disease ,ISOQUINOLINE alkaloids ,PATHOLOGY ,DNA methylation ,ANIMAL behavior - Abstract
Mitochondrial dysfunction is considered an early event of Alzheimer disease (AD). D-ribose is a natural monosaccharide that exists in cells, especially in mitochondria, and can lead to cognitive dysfunction. However, the reason for this is unclear. Berberine (BBR) is an isoquinoline alkaloid that can target mitochondria and has great prospect in the treatment of AD. The methylation of PINK1 reinforces the burden of Alzheimer's pathology. This study explores the role of BBR and D-ribose in the mitophagy and cognitive function of AD related to DNA methylation. APP/PS1 mice and N2a cells were treated with D-ribose, BBR, and mitophagy inhibitor Mdivi-1 to observe their effects on mitochondrial morphology, mitophagy, neuron histology, AD pathology, animal behavior, and PINK1 methylation. The results showed that D-ribose induced mitochondrial dysfunction, mitophagy damage, and cognitive impairment. However, BBR inhibition of PINK1 promoter methylation can reverse the above effects caused by D-ribose, improve mitochondrial function, and restore mitophagy through the PINK1–Parkin pathway, thus reducing cognitive deficits and the burden of AD pathology. This experiment puts a new light on the mechanism of action of D-ribose in cognitive impairment and reveals new insights in the use of BBR for AD treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Anti‐LINGO‐1 antibody treatment alleviates cognitive deficits and promotes maturation of oligodendrocytes in the hippocampus of APP/PS1 mice.
- Author
-
Yang, Hao, Jiang, Lin, Zhang, Yi, Liang, Xin, Tang, Jing, He, Qi, Luo, Yan‐Min, Zhou, Chun‐Ni, Zhu, Lin, Zhang, Shan‐Shan, Xiao, Kai, Zhu, Pei‐Lin, Wang, Jin, Li, Yue, Chao, Feng‐Lei, and Tang, Yong
- Abstract
Leucine‐rich repeat and immunoglobulin‐like domain‐containing nogo receptor‐interacting protein 1 (LINGO‐1), a negative regulator of oligodendrocyte differentiation and myelination, is associated with cognitive function, and its expression is highly upregulated in Alzheimer's disease (AD) patients. Anti‐LINGO‐1 antibody treatment can effectively antagonize the negative regulatory effect of LINGO‐1. In this study, we aim to assess the effect of anti‐LINGO‐1 antibody treatment on cognition and hippocampal oligodendrocytes in an AD transgenic animal model. First, 10‐month‐old male amyloid‐β (Aβ) protein precursor (APP)/presenilin 1 (PS1) mice were administered anti‐LINGO‐1 antibody for 8 weeks. Then, learning and memory abilities were assessed with the Morris water maze (MWM) and Y‐maze tests, and Aβ deposition and hippocampal oligodendrocytes were investigated by immunohistochemistry, immunofluorescence, and stereology. We found that anti‐LINGO‐1 antibody alleviated the deficits in spatial learning and memory abilities and working and reference memory abilities, decreased the density of LINGO‐1 positive cells, decreased Aβ deposition, significantly increased the number of mature oligodendrocytes and the density of myelin, reversed the abnormal increases in the number of oligodendrocyte lineage cells and the densities of oligodendrocytes precursor cells in APP/PS1 mice. Our results provide evidence that LINGO‐1 might be involved in the process of oligodendrocyte dysmaturity in the hippocampus of AD mice, and that antagonizing LINGO‐1 can alleviate cognitive deficits in APP/PS1 mice and decrease Aβ deposition and promote oligodendrocyte differentiation and maturation in the hippocampus of these mice. Our findings suggest that changes in LINGO‐1 and oligodendrocytes in the hippocampus play important roles in the pathogenesis of AD and that antagonizing LINGO‐1 might be a potential therapeutic strategy for AD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial.
- Author
-
Yang, Ziying, Zhang, Wenbo, Liu, Dunxiu, Zhang, Shan-shan, Tang, Yong, Song, Jiaqi, Long, Jinfeng, Yang, Jun, Jiang, Hong, Li, Yaling, Liu, Xintong, Lü, Yang, and Ding, Fu
- Subjects
ALZHEIMER'S disease ,MILD cognitive impairment ,RANDOMIZED controlled trials ,STATISTICAL sampling - Abstract
Objective: To investigate the effects of sport stacking on the overall cognition and brain function in patients with mild Alzheimer's disease (AD) and mild cognitive impairment (MCI). Methods: A single-blind randomized controlled design was performed using sport stacking for 30 min, 5 days/week for 12 weeks. Forty-eight subjects with mild AD or MCI were randomly divided into the sport stacking group (T-mAD = 12, T-MCI = 12) and the active control group (C-mAD = 11, C-MCI = 13). Auditory Verbal Learning Test (AVLT), Alzheimer's Disease Cooperative Study–Activities of Daily Living scale (ADCS-ADL), Geriatric Depression Scale (GDS-30), and Pittsburgh Sleep Quality Index (PSQI) were performed, the level of amyloid β-protein-40 (Aβ-40), Aβ-42, brain-derived neurotrophic factor (BDNF), insulin-like growth factor-1(IGF-1), tumor necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6), and soluble trigger receptor expressed on myeloid cells 2 (sTREM2) in plasma were tested, and brain functional connectivity in resting state and activation under finger movement task were analyzed by functional near-infrared spectroscopy (fNIRS). Results: Thirty-nine patients completed the trial. After 4 weeks, we found a significant increase in AVLT score in T-MCI (6.36 ± 5.08 vs. −1.11 ± 4.23, p = 0.004), and T-mAD group (4.60 ± 4.77 vs. −0.11 ± 2.89, p = 0.039). After 12 weeks, there was a significantly improved in AVLT (9.64 ± 4.90 vs. −0.33 ± 6.10, p = 0.002) and ADCS-ADL (3.36 ± 3.59 vs. −1.89 ± 2.71, p = 0.003) in T-MCI. There was a significant improvement in AVLT (5.30 ± 5.42 vs. 0.44 ± 2.40) in T-mAD (p < 0.05). Plasma levels of BDNF were upregulated in both T-MCI and T-mAD, and IGF-1 increased in T-MCI (P < 0.05) compared to the control groups. The functional connectivity in MCI patients between DLPFC.R and SCA.R, SMA.L, and SCA.R was decreased. In contrast, in mAD patients, the brain regional function connection was increased between DLPFC.R and Broca's.L. The activation of channel 36 located in the left primary somatosensory cortex was significantly increased after 12-week training, which was correlated with the improved AVLT and the increase of BDNF. Conclusion: Our findings suggested that sport stacking is effective for patients with MCI and mild AD, possibly through increasing the expression of neuroprotective growth factors and enhancing neural plasticity to improve neurocognitive performance. Clinical Trial Registration: https://www.ClinicalTrials.gov, ChiCTR.org.cn, identifier: ChiCTR-2100045980. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS.
- Author
-
Guo, Minsong, Zhu, Fengdan, Qiu, Wenqiao, Qiao, Gan, Law, Betty Yuen-Kwan, Yu, Lu, Wu, Jianming, Tang, Yong, Yu, Chonglin, Qin, Dalian, Zhou, Xiaogang, and Wu, Anguo
- Subjects
HIGH throughput screening (Drug development) ,AMYLOID ,INTERFEROMETRY ,TANDEM mass spectrometry ,DRUG development ,ALZHEIMER'S disease - Abstract
Discovery of drugs rapidly and effectively is an important aspect for Alzheimer's disease (AD). In this study, a novel high-throughput screening (HTS) method aims at screening the small-molecules with amyloid- β (A β) binding affinity from natural medicines, based on the combinational use of biolayer interferometry (BLI) and ultra-high-performance liquid chromatography coupled with diode-array detector and quadrupole/time-of-flight tandem mass spectrometry (UHPLC−DAD-Q/TOF-MS/MS) has been firstly developed. Briefly, the components in natural medicines disassociated from biotinylated A β were collected to analyze their potential A β binding affinity by UHPLC−DAD-Q/TOF-MS/MS. Here, baicalein was confirmed to exhibit the highest binding affinity with A β in Scutellaria baicalensis. Moreover, polyporenic acid C (PPAC), dehydrotumulosic acid (DTA), and tumulosic acid (TA) in Kai-Xin-San (KXS) were also identified as potent A β inhibitors. Further bioactivity validations indicated that these compounds could inhibit A β fibrillation, improve the viability in A β -induced PC-12 cells, and decrease the A β content and improve the behavioral ability in Caenorhabditis elegans. The molecular docking results confirmed that PPAC, DTA, and TA possessed good binding properties with A β. Collectively, the present study has provided a novel and effective HTS method for the identification of natural inhibitors on A β fibrillation, which may accelerate the process on anti-AD drugs discovery and development. A high-throughput screening (HTS) method based on the combinational use of biolayer interferometry (BLI) and UHPLC‒DAD-Q/TOF-MS/MS is developed. PPAC, DTA, and TA are identified from Kai-Xin-San as potent A β inhibitors. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS.
- Author
-
Zhao, Ya-Fei, Tang, Yong, and Illes, Peter
- Subjects
AMYOTROPHIC lateral sclerosis ,NEUROGLIA ,PARKINSON'S disease ,ALZHEIMER'S disease ,REACTIVE oxygen species - Abstract
P2X7 receptors are members of the ATP-gated cationic channel family with a preferential localization at the microglial cells, the resident macrophages of the brain. However, these receptors are also present at neuroglia (astrocytes, oligodendrocytes) although at a considerably lower density. They mediate necrosis/apoptosis by the release of pro-inflammatory cytokines/chemokines, reactive oxygen species (ROS) as well as the excitotoxic (glio)transmitters glutamate and ATP. Besides mediating cell damage i.e., superimposed upon chronic neurodegenerative processes in Alzheimer's Disease, Parkinson's Disease, multiple sclerosis, and amyotrophic lateral sclerosis, they may also participate in neuroglial signaling to neurons under conditions of high ATP concentrations during any other form of neuroinflammation/neurodegeneration. It is a pertinent open question whether P2X7Rs are localized on neurons, or whether only neuroglia/microglia possess this receptor-type causing indirect effects by releasing the above-mentioned signaling molecules. We suggest as based on molecular biology and functional evidence that neurons are devoid of P2X7Rs although the existence of neuronal P2X7Rs cannot be excluded with absolute certainty. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Raddeanin A isolated from Anemone raddeana Regel improves pathological and cognitive deficits of the mice model of Alzheimer's disease by targeting β-amyloidosis.
- Author
-
Liu, Meng Han, Tang, Yong, Qu, Li Qun, Song, Lin Lin, Lo, Hang Hong, Zhang, Rui Long, Yun, Xiao Yun, Wang, Hui Miao, Chan, Joyce Tsz Wai, Wu, Jian Hui, Wang, Cai Ren, Wong, Vincent Kam Wai, Wu, An Guo, and Law, Betty Yuen-Kwan
- Abstract
Raddeanin A is a triterpenoid isolated from Anemone raddeana Regel. It exhibits a broad spectrum of biological activities such as anti-tumor and anti-inflammatory, however, its neuroprotective effect in targeting Alzheimer's disease (AD) remains uninvestigated. To provide scientific base for the development of novel AD drug by clarifying the neuroprotective effect and molecular mechanisms of raddeanin A in both in vitro and in vivo AD model. To confirm the neuroprotective role of raddeanin A in the treatment of AD, its mechanisms and effects on β-amyloidosis and Aβ fibrillation was studied in U87 cells. Besides, the improvement on cognitive deficit, pathological defects, reactive astrocyte clusters, inhibition on neuronal inflammation and apoptosis were further studied in 3 x Tg-AD mice model of AD. Real-time PCR, western blot, dot blot, biolayer interferometry and bioinformatics analysis were used to confirm the in vitro effect and targets of raddeanin A on β-amyloidosis and its associated protein network. A series of experiments including Morris water maze, H&E staining, nissl staining and immunofluorescence analysis were conducted to confirm the protective behavioral effect of raddeanin A in the in vivo AD mice model. Raddeanin A was identified to reduce β-amyloidosis in U87 cells and 3 x Tg-AD mice model of AD by decreasing level of BACE1, APP, APP-β and Aβ. Raddeanin A improved behavioral, spatial memory and learning ability in the AD mice. In the cortex and hippocampus, raddeanin A improved the morphology and arrangement of neurons, lower the level of reactive astrocyte marker GFAP and apoptotic marker proteins Bax/Bcl2 ratio. Moreover, raddeanin A upregulated the mRNA and protein level of Prkcα in the hippocampus of AD mice whose neuroprotective effect was exerted possibly via the activation of protein kinase C. As a novel natural agent targeting β-amyloidosis, our results provide the first evidence of the multiple in vitro and in vivo neuroprotective effect of raddeanin A, suggesting its potential therapeutic application in preventing or alleviating the symptoms of AD. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Fluoxetine Promotes Hippocampal Oligodendrocyte Maturation and Delays Learning and Memory Decline in APP/PS1 Mice.
- Author
-
Chao, Feng-lei, Zhang, Yi, Zhang, Lei, Jiang, Lin, Zhou, Chun-ni, Tang, Jing, Liang, Xin, Fan, Jin-hua, Dou, Xiao-yun, and Tang, Yong
- Subjects
GLYCOGEN synthase kinase ,AMYLOID beta-protein precursor ,HIPPOCAMPUS (Brain) ,TRANSGENIC mice ,FLUOXETINE - Abstract
Oligodendrogenesis dysfunction impairs memory consolidation in adult mice, and an oligodendrocyte abnormality is an important change occurring in Alzheimer's disease (AD). While fluoxetine (FLX) is known to delay memory decline in AD models, its effects on hippocampal oligodendrogenesis are unclear. Here, we subjected 8-month-old male amyloid precursor protein (APP)/presenilin 1 (PS1) mice to the FLX intervention for 2 months. Their exploratory behaviors and general activities in a novel environment, spatial learning and memory and working and reference memory were assessed using the open-field test, Morris water maze, and Y maze. Furthermore, changes in hippocampal oligodendrogenesis were investigated using stereology, immunohistochemistry, immunofluorescence staining, and Western blotting techniques. FLX delayed declines in the spatial learning and memory, as well as the working and reference memory of APP/PS1 mice. In addition, APP/PS1 mice exhibited immature hippocampal oligodendrogenesis, and FLX increased the numbers of 2′3′cyclic nucleotide 3′-phosphodiesterase (CNPase)
+ and newborn CNPase+ oligodendrocytes in the hippocampi of APP/PS1 mice. Moreover, FLX increased the density of SRY-related HMG-box 10 protein (SOX10)+ cells and reduced the percentage of oligodendrocyte lineage cells displaying the senescence phenotype (CDKN2A/p16INK4a) in the hippocampus of APP/PS1 mice. Moreover, FLX had no effect on the serotonin (5-HT) 1A receptor (5-HT1AR) content or number of 5-HT1AR+ oligodendrocytes, but it reduced the content and activity of glycogen synthase kinase 3β (GSK3β) in the hippocampus of APP/PS1 transgenic mice. Taken together, FLX delays the senescence of oligodendrocyte lineage cells and promotes oligodendrocyte maturation in the hippocampus of APP/PS1 mice. FLX may regulate GSK3β through a mechanism other than 5-HT1AR and then inhibit the negative effect of GSK3β on oligodendrocyte maturation in the hippocampus of an AD mouse model. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
15. The seed of Litchi chinensis fraction ameliorates hippocampal neuronal injury in an Aβ25-35-induced Alzheimer's disease rat model via the AKT/GSK-3β pathway.
- Author
-
Sun, Yueshan, Wu, Anguo, Li, Xiu, Qin, Dalian, Jin, Bingjin, Liu, Jian, Tang, Yong, Wu, Jianming, and Yu, Chonglin
- Subjects
ANIMAL disease models ,RAT diseases ,ALZHEIMER'S disease ,MAZE tests ,COGNITIVE ability - Abstract
The seed of Litchi chinensis Sonn., a famous traditional Chinese medicine, was recently reported to enhance cognitive function by inhibiting neuronal apoptosis in rats. We determined whether the seed of Litchi chinensis fraction (SLF) can ameliorate hippocampal neuronal injury via the AKT/GSK-3β pathway. We established Alzheimer's disease (AD) model by infusing Aβ
25-35 into the lateral ventricle of Sprague–Dawley (SD) rats and randomly divided into five groups (n = 10): sham, donepezil and SLF (120, 240 and 480 mg/kg/d). Rats were treated by intragastric administration for 28 consecutive days. Spatial learning and memory were evaluated with Morris water maze, while protein expression of AKT, GSK-3β and tau in the hippocampal neurons was measured by Western blotting and immunohistochemistry. On the fifth day, escape latency of the AD model group was 45.78 ± 2.52 s and that of the sham operative group was 15.98 ± 2.32 s. SLF could improve cognitive functions by increasing the number of rats that crossed the platform (p < 0.01), and their platform quadrant dwell time (p < 0.05). The protein expression level of AKT was upregulated (p < 0.001), while that of GSK-3β and tau (p < 0.01) was remarkably downregulated in the hippocampal CA1 area. To our knowledge, the present study is the first to show that SLF may exert neuroprotective effect in AD rats via the AKT/GSK-3β signalling pathway, thereby serving as evidence for the potential utility of SLF as an effective drug against AD. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
16. CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease.
- Author
-
Liu, Zehui, Wang, Wanyan, Huang, Tingyu, Wang, Cunfang, Huang, Ying, Tang, Yong, and Huang, Jin
- Subjects
ALZHEIMER'S disease ,CELL survival - Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, and is the most common type of cognitive impairment and dementia. There is a pressing need to improve the clinical efficacy and quality of life for AD patients, as limited treatments options for AD patients have been developed until now. In this study, we aim to investigate the protective effect of CH(II), a cerebroprotein hydrolysate consisted of abundant biological peptides, on preclinical model of AD. We found that CH(II) treatment effectively protects oxygen glucose deprivation (OGD)-induced N2A cell viability impairment and cell apoptosis. In addition, CH(II) significantly reduces H
2 O2 -induced ROS accumulation and exhibits the protective activities against H2 O2 -induced oxidative injury. Intriguingly, we found that CH(II) treatment can effectively promote neurite outgrowth of N2A cells. Moreover, CH(II) obviously improve the cognitive and memorial function in scopolamine-induced amnesia mice model. Taken together, this study provides evidences of the neuroprotective activities of CH(II) and offers a potential therapeutic strategy for AD patients. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
17. Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease.
- Author
-
Zhou, Chun‐ni, Chao, Feng‐lei, Zhang, Yi, Jiang, Lin, Zhang, Lei, Fan, Jin‐hua, Wu, Yong‐xin, Dou, Xiao‐yun, and Tang, Yong
- Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with cognitive decline. Previous studies have reported that the syndrome of AD begins with subtle alterations in hippocampal synapses prior to frank neuronal degeneration. It has recently been reported that fluoxetine (FLX) shows positive effects on AD patients who have depression and anxiety. However, it is unclear whether FLX can affect the pathogenesis of AD mice in the early stage of AD. To address this question, 8‐month‐old male APP/PS1 double‐transgenic AD mice were administered a 10‐week course of FLX (10 mg/kg/day) injections. Then, spatial learning and memory were evaluated using a Morris water maze test. Immunohistological staining and an unbiased stereological method were used to estimate the total number of dendritic spine synapses in the hippocampus. We found that FLX significantly shortened the mean escape latencies of the 10‐month‐old mice; reduced the elevated levels of soluble Aβ40, Aβ42, and amyloid plaques in the hippocampus; and prevented the decrease in dendritic spine synapses and in postsynaptic protein PSD‐95 density in the dentate gyrus, CA1/2 and CA3 regions of the hippocampus. Our results indicate that reversing synaptic impairment might be considered a promising therapeutic approach for alleviating the cognitive deficits associated with early AD. Moreover, our results suggest that FLX may be a safe and effective drug for delaying the progress of AD, which might provide a starting point for further research into new preventative measures and treatments for AD. Using the unbiased stereological methods, we found that FLX prevented the decrease in dendritic spine synapses in the dentate gyrus, CA1/2 and CA3 regions of the hippocampus in the early Alzheimer's disease. This might provide a starting point for further research into new preventative measures and treatments for AD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Sex Differences in the White Matter and Myelinated Fibers of APP/PS1 Mice and the Effects of Running Exercise on the Sex Differences of AD Mice.
- Author
-
Zhou, Chun-ni, Chao, Feng-lei, Zhang, Yi, Jiang, Lin, Zhang, Lei, Luo, Yan-min, Xiao, Qian, Chen, Lin-mu, and Tang, Yong
- Subjects
ALZHEIMER'S disease ,COGNITIVE ability ,WHITE matter (Nerve tissue) ,HIPPOCAMPUS (Brain) ,EXERCISE - Abstract
Previous studies have suggested that changes in the white matter might play an important role in the pathogenic processes of Alzheimer's disease (AD). However, no study has investigated sex differences in these changes. Previous studies found that running exercise could delay both the decline in spatial learning and memory abilities as well as the changes in the white matter during early AD in male mice. However, whether exercise also has an effect on the changes in the white matter in female AD mice remains unknown. To address these questions, 6- and 10-month-old male and female APP/PS1 double transgenic AD mice were used. The 6-month-old male and female APP/PS1 double transgenic AD mice underwent a 4-month running exercise regime. The white matter volume and parameters of the myelinated fibers in the white matter of the 10-month-old exercised and non-exercised male and female AD mice were investigated using electron microscopy and stereological methods. There were no significant differences in the mean escape latencies between the male and female AD mice in the non-exercised groups, but after 4 months of treadmill exercise, the mean escape latencies of the female exercised AD mice had significantly shortened compared with those of the male exercised AD mice. The total white matter volume and most of the parameters of the myelinated fibers of the white matter in the female AD mice were significantly lower than those of the male AD mice. The total length of the myelinated fibers with diameters ranging from 0.6 to 0.7 μm, the axonal diameter of the myelinated fibers and the g-ratio of the myelinated fibers in the white matter of the exercised female AD mice were significantly increased compared with those of the non-exercised female AD mice. There were sex-specific differences in the white matter and myelinated fibers of white matter in the AD mice. Running exercise more effectively delayed the decline in spatial learning and memory abilities and delayed the changes in the myelinated fibers of the white matter in female transgenic mice with early AD than in male transgenic mice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Lychee Seed Fraction Inhibits Aγ(1-42)-Induced Neuroinflammation in BV-2 Cells via NF-κB Signaling Pathway.
- Author
-
Zhao, Ya, Zeng, Yuan, Wu, Anguo, Yu, Chonglin, Tang, Yong, Wang, Xiuling, Xiong, Rui, Chen, Haixia, Wu, Jianming, and Qin, Dalian
- Subjects
MICROGLIA ,APOPTOSIS ,ENZYME-linked immunosorbent assay - Abstract
In our previous studies, an active fraction derived from lychee seed could inhibit b-amyloid-induced apoptosis of PC12 cells and neurons. The primarily microglia cells are recognized as the brain's resident macrophages and thought to remodel of the brain by removing presumably redundant, apoptotic neurons. In the current study, we aimed to investigate the anti-neuroinflammation effect of lychee seed fraction (LSF) in Ab(1-42)- induced BV-2 cells and the underlying mechanism. The morphology results displayed that LSF could improve the status of Aβ(1-42)-induced BV-2 cells. The enzyme-linked immunosorbent assay, real-time PCR, and Western blotting results showed that LSF could significantly reduce the release, mRNA levels, and protein expressions of the pro-inflammatory cytokines such as interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-a), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) in Aβ(1-42)-induced BV-2 cells, which were downregulated through suppressing the NF-κB signaling pathway. Furthermore, LSF could upregulate Bcl-2 and downregulate Bax, Caspase-3, and cleaved-PARP protein expressions. Taken together, our results first demonstrated that LSF could suppress the inflammatory response via inhibiting NF- kB signaling pathway, and inhibit apoptosis in Ab(1-42)-induced BV-2 cells. Our findings further prove that LSF as a potential drug may be used for treating AD in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
20. Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS.
- Author
-
Illes, Peter, Rubini, Patrizia, Ulrich, Henning, Zhao, Yafei, and Tang, Yong
- Subjects
PURINERGIC receptors ,AMYOTROPHIC lateral sclerosis ,CENTRAL nervous system ,MICROGLIA ,PARKINSON'S disease ,ALZHEIMER'S disease ,FRACTALKINE ,GRANZYMES - Abstract
Microglial cells, the resident macrophages of the central nervous system (CNS), exist in a process-bearing, ramified/surveying phenotype under resting conditions. Upon activation by cell-damaging factors, they get transformed into an amoeboid phenotype releasing various cell products including pro-inflammatory cytokines, chemokines, proteases, reactive oxygen/nitrogen species, and the excytotoxic ATP and glutamate. In addition, they engulf pathogenic bacteria or cell debris and phagocytose them. However, already resting/surveying microglia have a number of important physiological functions in the CNS; for example, they shield small disruptions of the blood–brain barrier by their processes, dynamically interact with synaptic structures, and clear surplus synapses during development. In neurodegenerative illnesses, they aggravate the original disease by a microglia-based compulsory neuroinflammatory reaction. Therefore, the blockade of this reaction improves the outcome of Alzheimer's Disease, Parkinson's Disease, multiple sclerosis, amyotrophic lateral sclerosis, etc. The function of microglia is regulated by a whole array of purinergic receptors classified as P2Y12, P2Y6, P2Y4, P2X4, P2X7, A2A, and A3, as targets of endogenous ATP, ADP, or adenosine. ATP is sequentially degraded by the ecto-nucleotidases and 5′-nucleotidase enzymes to the almost inactive inosine as an end product. The appropriate selective agonists/antagonists for purinergic receptors as well as the respective enzyme inhibitors may profoundly interfere with microglial functions and reconstitute the homeostasis of the CNS disturbed by neuroinflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Polyphenols Derived from Lychee Seed Suppress Aβ (1-42)-Induced Neuroinflammation.
- Author
-
Tang, Yong, Xiong, Rui, Zhao, Ya, Qiu, Wen-Qiao, Wang, Xiu-Ling, Teng, Jin-Feng, Liu, Jian, Chen, Hai-Xia, Wu, An-Guo, Wu, Jian-Ming, Qin, Da-Lian, and Yu, Chong-Lin
- Subjects
- *
ALZHEIMER'S disease , *AMYLOID beta-protein , *LITCHI , *CATECHIN , *PROCYANIDINS - Abstract
Amyloid-β (Aβ) is commonly recognized as the most important factor that results in neuronal cell death and accelerates the progression of Alzheimer’s disease (AD). Increasing evidence suggests that microglia activated by Aβ release an amount of neurotoxic inflammatory cytokines that contribute to neuron death and aggravate AD pathology. In our previous studies, we found that lychee seed fraction (LSF), an active fraction derived from the lychee seed, could significantly improve the cognitive function of AD rats and inhibit Aβ-induced neuroinflammation in vitro, and decrease neuronal injuries in vivo and in vitro. In the current study, we aimed to isolate and identify the specific components in LSF that were responsible for the anti-neuroinflammation effect using preparative high performance liquid chromatography (pre-HPLC), liquid chromatography-mass spectrometry (LC-MS), and nuclear magnetic resonance (NMR) methods. To this end, we confirmed two polyphenols including catechin and procyanidin A2 that could improve the morphological status of BV-2 cells and suppress the release, mRNA levels, and protein expression of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) through downregulating the nuclear factor-κB (NF-κB) signaling pathway using ELISA, RT-PCR, and Western blotting methods. Furthermore, catechin and procyanidin A2 could inhibit Aβ-induced apoptosis in BV-2 cells by upregulating Bcl-2 and downregulating Bax protein expression. Therefore, the current study illustrated the active substances in lychee seed, and first reported that catechin and procyanidin A2 could suppress neuroinflammation in Aβ-induced BV-2 cells, which provides detailed insights into the molecular mechanism of catechin and procyanidin A2 in the neuroprotective effect, and their further validations of anti-neuroinflammation in vivo is also essential in future research. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. Anti-LINGO-1 antibody protects neurons and synapses in the medial prefrontal cortex of APP/PS1 transgenic mice.
- Author
-
Zhou, Yu-Ning, Jiang, Lin, Zhang, Yi, Zhou, Chun-Ni, Yang, Hao, He, Qi, Wang, Yi-Ying, Xiao, Qian, Huang, Du-Juan, Luo, Yan-Min, Tang, Yong, and Chao, Feng-Lei
- Subjects
- *
DENDRITIC spines , *TRANSGENIC mice , *PREFRONTAL cortex , *NEURONS , *SYNAPSES , *CENTRAL nervous system - Abstract
The medial prefrontal cortex (mPFC), one of the most vulnerable brain regions in Alzheimer's disease (AD), plays a critical role in cognition. Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein-1 (LINGO-1) negatively affects nerve growth in the central nervous system; however, its role in the pathological damage to the mPFC remains to be studied in AD. In this study, an anti-LINGO-1 antibody was administered to 10-month-old APP/PS1 mice, and behavioral tests, stereological methods, immunohistochemistry and immunofluorescence were used to answer this question. Our results revealed that LINGO-1 was highly expressed in the neurons of the mPFC of AD mice, and the anti-LINGO-1 antibody improved prefrontal cortex-related function and reduced the protein level of LINGO-1, atrophy of the volume, Aβ deposition and massive losses of synapses and neurons in the mPFC of AD mice. Antagonizing LINGO-1 could effectively alleviate the pathological damage in the mPFC of AD mice, which might be an important structural basis for improving prefrontal cortex-related function. Abnormal expression of LINGO-1 in the mPFC may be one of the key targets of AD, and the effect initiated by the anti-LINGO-1 antibody may provide an important basis in the search for drugs for the prevention and treatment of AD. • Anti-LINGO-1 antibody delays atrophy of the mPFC and reduces Aβ deposition in the mPFC in AD mice. • Anti-LINGO-1 antibody decreases the neuronal LINGO-1 protein in the mPFC of AD mice. • Anti-LINGO-1 antibody delays the losses of neurons and dendritic spines in the mPFC of AD mice. • Anti-LINGO-1 antibody increases the synapses on the neurite in the mPFC of AD mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Proinflammatory S100A9 stimulates TLR4/NF-κB signaling pathways causing enhanced phagocytic capacity of microglial cells.
- Author
-
Zhang, Xiaoyin, Sun, Dan, Zhou, Xin, Zhang, Ce, Yin, Qing, Chen, Li, Tang, Yong, Liu, Yonggang, and Morozova-Roche, Ludmilla A
- Subjects
- *
MICROGLIA , *CELLULAR signal transduction , *ALZHEIMER'S disease , *PHAGOCYTOSIS , *IMMUNE response - Abstract
• S100A9 promotes the microglial phagocytosis in dose-dependent manners. • S100A9 regulates microglial phagocytosis through TLR4/NF-κB pathways. • Cytoskeleton reorganization is essential for microglial phagocytosis. Alzheimer's disease (AD) is the main cause of dementia, affecting the increasingly aging population. Growing evidence indicates that neuro-inflammation plays crucial roles, e.g., the association between AD risk genes with innate immune functions. In this study, we demonstrate that moderate concentrations of pro-inflammatory cytokine S100A9 regulate immune response of BV2 microglial cells, i.e., the phagocytic capacity, reflected by elevated number of 1 μm diameter Dsred-stained latex beads in the cytoplasm. In contrast, at high S100A9 concentrations, both the viability and phagocytic capacity of BV2 cells drop substantially. Furthermore, it is uncovered that S100A9 affects phagocytosis of microglia via NF-κB signaling pathways. Application of related target-specific drugs, i.e., IKK and TLR4 inhibitors, effectively suppresses BV2 cells' immune responses. These results suggest that pro-inflammatory S100A9 activates microglial phagocytosis, and possibly contributes to the clearance of amyloidogenic species at the early stage of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
- Author
-
Xie, Yu-han, Jiang, Lin, Zhang, Yi, Deng, Yu-hui, Yang, Hao, He, Qi, Zhou, Yu-ning, Zhou, Chun-ni, Luo, Yan-min, Liang, Xin, Wang, Jin, Huang, Du-juan, Zhu, Lin, Tang, Yong, and Chao, Feng-lei
- Subjects
- *
DENDRITIC spines , *TRANSGENIC mice , *MICROGLIA , *HIPPOCAMPUS (Brain) , *ALZHEIMER'S disease - Abstract
• AD mice has more postsynaptic terminal colocalized with microglia in the hippocampi. • Anti-LINGO-1 antibody rescues the loss of postsynaptic terminal in AD hippocampi. • Microglia might participate in the effect of Anti-LINGO-1 antibody in AD. In Alzheimer's disease (AD), microglia are involved in synaptic pruning and mediate synapse loss. LINGO-1 is a negative regulator of nerve growth, and whether antagonizing LINGO-1 can attenuate synaptic pruning by microglia and rescue dendritic spines in the hippocampus in AD is still unclear. On this basis, the anti-LINGO-1 antibody, which binds to LINGO-1 protein and antagonizes the effects of LINGO-1, was administered to 10-month-old APP/PS1 transgenic mice for 2 months. The Morris water maze test, immunohistochemical and stereological methods, immunofluorescence and 3D reconstruction were used. Compared to wild-type mice, APP/PS1 transgenic mice had worse performance on behavioral tests, fewer dendritic spines but more microglia in the hippocampus. Meanwhile, the microglia in APP/PS1 transgenic mice had more branches of medium length (4–6 µm) and a cell body area with greater variability. Moreover, APP/PS1 transgenic mice had more postsynaptic termini colocalized with microglia in the hippocampus than wild-type mice. The anti-LINGO-1 antibody significantly reversed these changes in AD, indicating that the anti-LINGO-1 antibody can improve hippocampus-dependent learning and memory abilities and effectively rescue dendritic spines in the hippocampus of AD mice and that microglia might participate in this progression in AD. These results provide a scientific basis for further studying the mechanism of the anti-LINGO-1 antibody in AD and help to elucidate the role of LINGO-1 in the treatment of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
- Author
-
Qiu, Wen-Qiao, Pan, Rong, Tang, Yong, Zhou, Xiao-Gang, Wu, Jian-Ming, Yu, Lu, Law, Betty Yuen-Kwan, Ai, Wei, Yu, Chong-Lin, Qin, Da-Lian, and Wu, An-Guo
- Subjects
- *
NLRP3 protein , *LITCHI , *ALZHEIMER'S disease , *SEEDS , *INFLAMMATION - Abstract
• LSP, a bioactive fraction enriching polyphenol from lychee seed, activates autophagy via the LRP1/AMPK-regulated autophagy in BV-2 cells. • LRP1 negatively regulates the NLRP3 inflammasome in Aβ(1-42)-induced BV-2 cells. • LSP inhibits the NLRP3 inflammasome-mediated neuroinflammation in Aβ(1-42)-induced BV-2 cells via the LRP1/AMPK signaling pathway. • LSP improves the cognitive function and inhibits the NLRP3 inflammasome in APP/PS1 mice. Emerging evidence indicates that the enhancement of microglial autophagy inhibits the NLRP3 inflammasome mediated neuroinflammation in Alzheimer's disease (AD). Meanwhile, low density lipoprotein receptor-related protein 1 (LRP1) highly expressed in microglia is able to negatively regulate neuroinflammation and positively regulate autophagy. In addition, we have previously reported that an active lychee seed fraction enriching polyphenol (LSP) exhibits anti-neuroinflammation in Aβ-induced BV-2 cells. However, its molecular mechanism of action is still unclear. In this study, we aim to investigate whether LSP inhibits the NLRP3 inflammasome mediated neuroinflammation and clarify its molecular mechanism in Aβ-induced BV-2 cells and APP/PS1 mice. The results showed that LSP dose- and time-dependently activated autophagy by increasing the expression of Beclin 1 and LC3II in BV-2 cells, which was regulated by the upregulation of LRP1 and its mediated AMPK signaling pathway. In addition, both the Western blotting and fluorescence microscopic results demonstrated that LSP could significantly suppress the activation of NLRP3 inflammasome by inhibiting the expression of NLRP3, ASC, the cleavage of caspase-1, and the release of IL-1β in Aβ(1-42)-induced BV-2 cells. In addition, the siRNA LRP1 successfully abolished the effect of LSP on the activation of AMPK and its mediated autophagy, as well as the inhibition of NLRP3 inflammasome. Furthermore, LSP rescued PC-12 cells which were induced by the conditioned medium from Aβ(1-42)-treated BV-2 cells. Moreover, LSP improved the cognitive function and inhibited the NLRP3 inflammasome in APP/PS1 mice. Taken together, LSP inhibited the NLRP3 inflammasome-mediated neuroinflammation in the in vitro and in vivo models of AD, which was closely associated with the LRP1/AMPK-mediated autophagy. Thus, the findings from this study further provide evidences for LSP serving as a potential drug for the treatment of AD in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice.
- Author
-
Wang, Yi-ying, Zhou, Yu-ning, Jiang, Lin, Wang, Shun, Zhu, Lin, Zhang, Shan-shan, Yang, Hao, He, Qi, Liu, Li, Xie, Yu-han, Liang, Xin, Tang, Jing, Chao, Feng-lei, and Tang, Yong
- Subjects
- *
RECEPTOR for advanced glycation end products (RAGE) , *TRANSGENIC mice , *DENDRITIC spines , *HIPPOCAMPUS (Brain) , *ADVANCED glycation end-products , *ALZHEIMER'S disease - Abstract
Alzheimer's disease (AD) is closely related to hippocampal synapse loss, which can be alleviated by running exercise. However, further studies are needed to determine whether running exercise reduces synapse loss in the hippocampus in an AD model by regulating microglia. Ten-month-old male wild-type mice and APP/PS1 mice were randomly divided into control and running groups. All mice in the running groups were subjected to voluntary running exercise for four months. After the behavioral tests, immunohistochemistry, stereological methods, immunofluorescence staining, 3D reconstruction, western blotting and RNA-Seq were performed. Running exercise improved the spatial learning and memory abilities of APP/PS1 mice and increased the total number of dendritic spines, the levels of the PSD-95 and Synapsin Ia/b proteins, the colocalization of PSD-95 and neuronal dendrites (MAP-2) and the number of PSD-95-contacting astrocytes (GFAP) in the hippocampi of APP/PS1 mice. Moreover, running exercise reduced the relative expression of CD68 and Iba-1, the number of Iba-1+ microglia and the colocalization of PSD-95 and Iba-1+ microglia in the hippocampi of APP/PS1 mice. The RNA-Seq results showed that some differentially expressed genes (DEGs) related to the complement system (Cd59b , Serping1 , Cfh , A2m , and Trem2) were upregulated in the hippocampi of APP/PS1 mice, while running exercise downregulated the C3 gene. At the protein level, running exercise also reduced the expression of advanced glycation end products (AGEs), receptor for advanced glycation end products (RAGE), C1q and C3 in the hippocampus and AGEs and RAGE in hippocampal microglia in APP/PS1 mice. Furthermore, the Col6a3 , Scn5a , Cxcl5 , Tdg and Clec4n genes were upregulated in the hippocampi of APP/PS1 mice but downregulated after running, and these genes were associated with the C3 and RAGE genes according to protein–protein interaction (PPI) analysis. These findings indicate that long-term voluntary exercise might protect hippocampal synapses and affect the function and activation of microglia, the AGE/RAGE signaling pathway in microglia and the C1q/C3 complement system in the hippocampus in APP/PS1 mice, and these effects may be related to the Col6a3 , Scn5a , Cxcl5 , Tdg and Clec4n genes. The current results provide an important basis for identifying targets for the prevention and treatment of AD. • Voluntary exercise prevented spatial learning and memory decline in APP/PS1 mice. • Voluntary exercise improved the number of dendritic spines and expression of synapse-related proteins in the hippocampi of APP/PS1 mice. • Voluntary exercise reduced the number of microglia, colocalization of synapses and microglia, AGE/RAGE signaling pathway in microglia and C1q/C3 complement system in the hippocampi of APP/PS1 mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease.
- Author
-
Ribeiro, Deidiane Elisa, Petiz, Lyvia Lintzmaier, Glaser, Talita, Oliveira-Giacomelli, Ágatha, Andrejew, Roberta, Saab, Fernando de Azevedo Ribeiro, Milanis, Milena da Silva, Campos, Henrique Correia, Sampaio, Vanessa Fernandes Arnaud, La Banca, Sophia, Longo, Beatriz Monteiro, Lameu, Claudiana, Tang, Yong, Resende, Rodrigo Ribeiro, Ferreira, Sergio T., and Ulrich, Henning
- Subjects
- *
ALZHEIMER'S disease , *COGNITION disorders , *PURINERGIC receptors , *SLEEP disorders , *AFFECTIVE disorders , *CENTRAL nervous system - Abstract
About 10 million new cases of dementia develop worldwide each year, of which up to 70% are attributable to Alzheimer's disease (AD). In addition to the widely known symptoms of memory loss and cognitive impairment, AD patients frequently develop non-cognitive symptoms, referred to as behavioral and psychological symptoms of dementia (BPSDs). Sleep disorders are often associated with AD, but mood alterations, notably depression and apathy, comprise the most frequent class of BPSDs. BPSDs negatively affect the lives of AD patients and their caregivers, and have a significant impact on public health systems and the economy. Because treatments currently available for AD are not disease-modifying and mainly aim to ameliorate some of the cognitive symptoms, elucidating the mechanisms underlying mood alterations and other BPSDs in AD may reveal novel avenues for progress in AD therapy. Purinergic signaling is implicated in the pathophysiology of several central nervous system (CNS) disorders, such as AD, depression and sleep disorders. Here, we review recent findings indicating that purinergic receptors, mainly the A 1 , A 2A , and P2X7 subtypes, are associated with the development/progression of AD. Current evidence suggests that targeting purinergic signaling may represent a promising therapeutic approach in AD and related conditions. This article is part of the Special Issue on "Purinergic Signaling: 50 years". [Display omitted] • Mood and sleep disorders are frequent comorbidities in Alzheimer's disease. • Purinergic signaling is implicated in Alzheimer's disease, depression and sleep disorders. • A 1 receptor stimulation and A 2A or P2X7 receptor inhibition are neuroprotective. • Purinergic signaling may comprise a therapeutic target in Alzheimer's disease and comorbidities. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. The early changes in behavior and the myelinated fibers of the white matter in the Tg2576 transgenic mouse model of Alzheimer's disease.
- Author
-
Zhang, Lei, Lu, Wei, Chen, Lin, Qiu, Xuan, Li, Chen, Huang, Chun-xia, Gong, Xia, Min, Qi-cheng, Lu, Fang, Wan, Jing-yuan, Chao, Feng-lei, and Tang, Yong
- Subjects
- *
BEHAVIORAL research , *WHITE matter (Nerve tissue) , *CENTRAL nervous system , *TRANSGENIC mice , *ALZHEIMER'S disease - Abstract
Highlights: [•] The Aβ deposition in the white matter appeared before the change in spatial learning memory. [•] The axon change in the white matter might be one of the morphological causes of the behavioral deficits. [•] The early detection of the Aβ content in the white matter might help diagnose suspected AD. [•] Protecting the axons in the white matter might be an important method for delaying the progression of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
29. Activity-Induced Convergence of APP and BACE-1 in Acidic Microdomains via an Endocytosis-Dependent Pathway.
- Author
-
Das, Utpal, Scott, David?A., Ganguly, Archan, Koo, Edward?H., Tang, Yong, and Roy, Subhojit
- Subjects
- *
CONVERGENT evolution , *ALZHEIMER'S disease , *ENDOCYTOSIS , *PROTEIN precursors , *SECRETORY granules , *CLATHRIN - Abstract
Summary: The convergence of APP (substrate) and BACE-1 (enzyme) is a rate-limiting, obligatory event triggering the amyloidogenic pathway—a key step in Alzheimer’s disease (AD) pathology. However, as both APP/BACE-1 are highly expressed in brain, mechanisms precluding their unabated convergence are unclear. Exploring dynamic localization of APP/BACE-1 in cultured hippocampal neurons, we found that after synthesis via the secretory pathway, dendritic APP/BACE-1-containing vesicles are largely segregated in physiologic states. While BACE-1 is sorted into acidic recycling endosomes, APP is conveyed in Golgi-derived vesicles. However, upon activity induction—a known trigger of the amyloidogenic pathway—APP is routed into BACE-1-positive recycling endosomes via a clathrin-dependent mechanism. A partitioning/convergence of APP/BACE-1 vesicles is also apparent in control/AD brains, respectively. Considering BACE-1 is optimally active in an acidic environment, our experiments suggest that neurons have evolved trafficking strategies that normally limit APP/BACE-1 proximity and also uncover a pathway routing APP into BACE-1-containing organelles, triggering amyloidogenesis. Video Abstract: Display Omitted [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
30. Polyphenols isolated from lychee seed inhibit Alzheimer's disease-associated Tau through improving insulin resistance via the IRS-1/PI3K/Akt/GSK-3β pathway.
- Author
-
Xiong, Rui, Wang, Xiu-Ling, Wu, Jian-Ming, Tang, Yong, Qiu, Wen-Qiao, Shen, Xin, Teng, Jin-Feng, Pan, Rong, Zhao, Ya, Yu, Lu, Liu, Jian, Chen, Hai-Xia, Qin, Da-Lian, Yu, Chong-Lin, and Wu, An-Guo
- Subjects
- *
ALZHEIMER'S disease , *CELLULAR signal transduction , *CHROMATOGRAPHIC analysis , *EPITHELIAL cells , *FLUORESCENT antibody technique , *GENE expression , *HERBAL medicine , *INSULIN , *CHINESE medicine , *MESSENGER RNA , *NERVE tissue proteins , *PHOSPHORYLATION , *POLYMERASE chain reaction , *POLYPHENOLS , *PROTEIN kinases , *SEEDS , *WESTERN immunoblotting , *DEXAMETHASONE , *SIGNAL peptides - Abstract
Lychee seed, the seed of Litchi chinensis Sonn. is one of the commonly used in traditional Chinese medicine (TCM). It possesses many pharmacological effects such as blood glucose and lipid-lowering effects, liver protection, and antioxidation. Our preliminary studies have proven that an active fraction derived from lychee seed (LSF) can significantly decrease the blood glucose level, inhibit amyloid-β (Aβ) fibril formation and Tau hyperphosphorylation, and improve the cognitive function and behavior of Alzheimer's disease (AD) model rats. The aim of this study was to identify the main active components in LSF that can inhibit the hyperphosphorylation of Tau through improving insulin resistance (IR) in dexamethasone (DXM)-induced HepG2 and HT22 cells. The isolation was guided by the bioactivity evaluation of the improvement effect of IR in HepG2 and HT22 cells. The mRNA and protein expressions of IRS-1, PI3K, Akt, GSK-3β, and Tau were measured by RT-PCR, Western blotting, and immunofluorescence methods, respectively. After extraction, isolation, and elucidation using chromatography and spectrum technologies, three polyphenols including catechin, procyanidin A1 and procyanidin A2 were identified from fractions 3, 5, and 9 derived from LSF. These polyphenols inhibit hyperphosphorylated Tau via the up-regulation of IRS-1/PI3K/Akt and down-regulation of GSK-3β. Molecular docking result further demonstrate that these polyphenols exhibit good binding property with insulin receptor. catechin, procyanidin A1, and procyanidin A2 are the main components in LSF that inhibit Tau hyperphosphorylation through improving IR via the IRS-1/PI3K/Akt/GSK-3β pathway. Therefore, the findings in the current study provide novel insight into the anti-AD mechanism of the components in LSF derived from lychee seed, which is valuable for the further development of a novel drug or nutrient supplement for the prevention and treatment of AD. Image 1 [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the hippocampus of APP/PS1 transgenic mice.
- Author
-
Zhang, Lei, Tang, Wei, Chao, Feng-lei, Zhou, Chun-ni, Jiang, Lin, Zhang, Yi, Liang, Xin, Tang, Jing, Qi, Ying-qiang, Yang, Hao, He, Qi, Zhang, Shan-shan, Zhu, Lin, Peng, Yan, and Tang, Yong
- Subjects
- *
TRANSGENIC mice , *TREADMILL exercise , *TREADMILLS , *SPATIAL memory , *MEMORY loss , *INTELLIGENCE tests , *LONG-term synaptic depression - Abstract
Previous studies have reported that exercise could improve the plasticity of hippocampal synapses. However, the effects of exercise on synapses in the hippocampus in Alzheimer's disease (AD) are not completely known. In this study, thirty 12-month-old male APP/PS1 double transgenic mice were randomly divided into a sedentary group (n = 15) and a running group (n = 15). Fifteen 12-month-old male wild-type littermates were assigned to the control group (n = 15). While running mice were assigned to treadmill running for four months, the control mice and sedentary mice did not run during the study period. After Morris water maze testing, five mice in each group were randomly selected for a stereological assessment of spinophilin-immunoreactive puncta in the CA1, CA2–3 and dentate gyrus (DG) of the hippocampus. Morris water maze testing revealed that while the learning and memory abilities in sedentary APP/PS1 mice were significantly worse than those in wild-type control mice, the learning and memory abilities in running APP/PS1 mice were significantly better than those in sedentary APP/PS1 mice. The stereological results showed that the spinophilin-immunoreactive puncta numbers of the CA1, CA2–3 and DG in the hippocampus of sedentary APP/PS1 mice were significantly lower than those of wild-type control mice and that the numbers of these spines in the CA1, CA2–3 and DG in the hippocampus of running APP/PS1 mice were significantly higher than those of sedentary APP/PS1 mice. Moreover, a running-induced improvement in spatial learning and memory abilities was significantly correlated with running-induced increases in the spinophilin-immunoreactive puncta numbers in the CA1 and DG of the hippocampus. Four-month treadmill exercise induced a significant improvement in spatial learning and memory abilities and a significant increase in the number of spinophilin-immunoreactive puncta of the CA1, CA2–3 and DG in the hippocampus of APP/PS1 mice. Running-induced improvements in spatial learning and memory abilities were significantly correlated with running-induced increases in the spinophilin-immunoreactive puncta numbers in the CA1 and DG of the hippocampus. • Four-month treadmill exercise improves spatial learning and memory in APP/PS1 mice. • Four-month treadmill exercise increases dendritic spine numbers in the CA1, CA2–3 and DG of APP/PS1 mice. • Running exercise may be an effective means to delay dementia symptoms in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Quantitative study of the capillaries within the white matter of the Tg2576 mouse model of Alzheimer's disease.
- Author
-
Zhang, Yi, Chao, Feng‐lei, Zhang, Lei, Jiang, Lin, Zhou, Chun‐ni, Chen, Lin‐mu, Lu, Wei, Jiang, Rong, and Tang, Yong
- Subjects
- *
MAZE tests , *ALZHEIMER'S disease , *CAPILLARIES , *TRANSGENIC mice , *QUANTITATIVE research - Abstract
Introduction: To quantitatively investigate the capillaries within the white matter of Tg2576 Alzheimer's disease (AD) transgenic mice during the early stage. Methods: In the current study, 10‐month‐old male Tg2576 AD mice were used as the early‐stage AD group and age‐matched nontransgenic littermate mice were used as the wild‐type group. Then, the Morris water maze was used to examine the spatial learning and memory abilities of the mice in both groups, and unbiased stereological methods were used to accurately quantify the volume of white matter and the parameters of the capillaries within the white matter, such as the total length, total volume, and total surface area of capillaries. Results: The Morris water maze performance of the Tg2576 group was worse than that of the wild‐type group, while the white matter volume did not significantly differ between the wild‐type group and the Tg2576 group. The total length, total volume, and total surface area of the capillaries within the white matter of the Tg2576 group were significantly decreased compared to those of the wild‐type group. Conclusions: The current study provide structural basis for understanding the pathological changes of the early stage of AD and cognitive decline in AD might be associated with changes in the white matter capillaries. Capillaries within the white matter might, thus, serve as a valid target for the prevention and treatment of early‐stage AD. (a) Capillary changes within the white matter were found in early‐stage AD mice. (b) Capillary microcirculation changes were present before white matter atrophy in AD. (c) Capillaries within the white matter may serve as an early target for the prevention of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.